Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

entrectinib MeSH Supplementary Concept Data 2026


MeSH Supplementary
entrectinib
Unique ID
C000607349
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000607349
Entry Term(s)
N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide
NMS-E628
RXDX-101
Rozlytrek
Pharm Action
Protein Kinase Inhibitors
Registry Numbers
L5ORF0AN1I
Heading Mapped to
*Benzamides
*Indazoles
Frequency
117
Note
inhibits TRK, ROS1, and ALK receptor tyrosine kinases; structure in first source
Source
Br J Cancer. 2015 Dec 22;113(12):1730-4.
Date Introduced
2016/05/07
Last Updated
2019/08/28
entrectinib Preferred
RXDX-101 Narrower
NMS-E628 Narrower
Rozlytrek Related
page delivered in 0.004s